DUBLIN--(BUSINESS WIRE)--The "Mouth Ulcer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
The global mouth ulcer treatment market reached a value of US$ 1.1 Billion in 2017.
Some of the major factors which are leading to mouth ulcers include stress, infection, injury, allergy, unhealthy lifestyles such as high consumption of junk foods and tobacco, etc.
Catalyzed by a rising incidence of mouth ulcers, the market for mouth ulcer treatment is also undergoing strong growth. Factors such as rising awareness on modern treatment options, increasing geriatric population, availability of rapid healing and easy to use products, etc., are also creating a positive impact on the market.
Looking forward, the global mouth ulcer treatment market is expected to reach a value of US$ 1.3 Billion by 2023, exhibiting a CAGR of 3.7% during 2018-2023.
The competitive landscape of the market has also been examined with some of the key players being Blistex Inc; Church & Dwight Co. Inc.; 3M; Colgate-Palmolive Company; GlaxoSmithKline, Plc.; Bristol Myers Squibb Company; and Pfizer Inc.
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
5 Global Mouth Ulcer Treatment Market
6 Market Breakup by Formulation
7 Market Breakup by Drug Class
8 Market Breakup by Indication
9 Market Breakup by Region
10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
- Blistex Inc
- Church & Dwight Co. Inc.
- 3M
- Colgate-Palmolive Company
- GlaxoSmithKline
- Plc.Bristol Myers Squibb Company
- Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/research/zb3s4p/global_mouth?w=4
